Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-009566
Filing Date
2025-01-21
Accepted
2025-01-21 16:24:20
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d907390ds3.htm S-3 169177
2 EX-5.1 d907390dex51.htm EX-5.1 10087
3 EX-23.2 d907390dex232.htm EX-23.2 1657
4 EX-FILING FEES d907390dexfilingfees.htm EX-FILING FEES 17610
5 GRAPHIC g907390g00m01.jpg GRAPHIC 41079
6 GRAPHIC g907390g0117203432631.jpg GRAPHIC 2534
  Complete submission text file 0001193125-25-009566.txt   259513
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-284380 | Film No.: 25542761
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)